Farabi Pharmaceutical (XTEH:DFRB1) Inventories, Work In Process: IRR0.00 Mil (As of . 20)


What is Farabi Pharmaceutical Inventories, Work In Process?

Farabi Pharmaceutical XTEH:DFRB1 Inventories, Work In Process is IRR0.00 Mil as of . 20.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Farabi Pharmaceutical's work in process for the quarter that ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Inventories, Work In Process Chart

Farabi Pharmaceutical Annual Data
Trend
Inventories, Work In Process

Farabi Pharmaceutical Quarterly Data
Inventories, Work In Process

Farabi Pharmaceutical Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Inventories, Work In Process of IRR0.00 Mil as of . 20. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Inventories, Work In Process too high?
Farabi Pharmaceutical's current Inventories, Work In Process is IRR0.00 Mil.
How does Farabi Pharmaceutical's Inventories, Work In Process compare to IMNPQ and INNV?
Farabi Pharmaceutical's Inventories, Work In Process of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Inventories, Work In Process is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Inventories, Work In Process of IRR0.00 Mil. The current Inventories, Work In Process is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Inventories, Work In Process is IRR0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.